| Literature DB >> 18840473 |
G Bezzina1, F S den Boon, C L Hampson, T H C Cheung, S Body, C M Bradshaw, E Szabadi, I M Anderson, J F W Deakin.
Abstract
UNLABELLED: The subthalamic nucleus (STN), a major relay in the indirect striatofugal pathway, plays an important role in extrapyramidal motor control. Recent evidence indicates that it may also be involved in regulating the incentive value of food reinforcers.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18840473 PMCID: PMC3098367 DOI: 10.1016/j.bbr.2008.09.005
Source DB: PubMed Journal: Behav Brain Res ISSN: 0166-4328 Impact factor: 3.332
Fig. 2Overall response rates under the progressive-ratio schedule during the final 10 sessions of each phase of the experiment. Ordinate: response rate (responses min−1); abscissa: response/reinforcer ratio. Points are group mean data from the sham-lesioned (open symbols) and STN-lesioned (filled symbols) groups. The curves are fits of Eq. (1) to the data. See text for details of analysis. Triangles are data points excluded from the function-fitting (see text for explanation).
Fig. 1Upper histogram: highest completed ratio. Lower histogram: peak response rate (responses min−1). Bars show group mean data ± SEM, for the sham-lesioned group (white) and the STN-lesioned group (black), in each phase of the experiment. * Significantly higher ratio in both groups in phase 2 than in phases 1 and 3 (P < 0.05); # Significantly lower peak response rate in the STN-lesioned group than in the sham-lesioned group in all three phases of the experiment (see text for details).
Fig. 3Performance in successive ratios of the progressive-ratio schedule during the final 10 sessions of each phase of the experiment. Upper panels: Post-reinforcement pause, ordinate, pause duration (s). Lower panels: Running response rate (response rate calculated after exclusion of the post-reinforcement pause), ordinate, running rate (responses min−1). Other conventions are as in Fig. 1.
Estimated parameters of Eq. (1), goodness of fit (r) and numbers of data points excluded from the function-fitting (mean ± SEM) of the STN-lesioned and sham-lesioned groups on three phases of the experiment (see text for explanation).
| Parameter | Sham-lesioned group | STN-lesioned group |
|---|---|---|
| ‘Specific activation’, | ||
| Phase 1 (one pellet) | 149.8 ± 19.9 | 201.6 ± 37.6 |
| Phase 2 (two pellets) | 204.7 ± 25.0 | 308.4 ± 33.2 |
| Phase 3 (one pellet) | 133.0 ± 21.0 | 186.5 ± 29.7 |
| ‘Response time’, | ||
| Phase 1 (one pellet) | 1.09 ± 0.09 | 1.41 ± 0.12 |
| Phase 2 (two pellets) | 1.14 ± 0.09 | 1.51 ± 0.13 |
| Phase 3 (one pellet) | 0.99 ± 0.06 | 1.35 ± 0.12 |
| ‘Currency parameter’, | ||
| Phase 1 (one pellet) | 0.40 ± 0.08 | 0.54 ± 0.10 |
| Phase 2 (two pellets) | 0.41 ± 0.10 | 0.38 ± 0.10 |
| Phase 3 (one pellet) | 0.59 ± 0.09 | 0.59 ± 0.11 |
| Goodness of fit, | ||
| Phase 1 (one pellet) | 0.88 ± 0.01 | 0.83 ± 0.02 |
| Phase 2 (two pellets) | 0.72 ± 0.06 | 0.70 ± 0.05 |
| Phase 3 (one pellet) | 0.79 ± 0.03 | 0.75 ± 0.04 |
| Number of data points excluded | ||
| Phase 1 (one pellet) | 0.4 ± 0.2 | 0.6 ± 0.2 |
| Phase 2 (two pellets) | 0.4 ± 0.2 | 0.1 ± 0.1 |
| Phase 3 (one pellet) | 0.3 ± 0.2 | 0.1 ± 0.1 |
Significant effects of group and phase (P < 0.05), no significant interaction.
Significant effect of group (P < 0.05), no significant of phase and no significant interaction.
Fig. 4Left-hand panels: sample photomicrographs from NeuN-stained coronal sections of the brains of a sham-lesioned rat (upper panel) and an STN-lesioned rat (lower panel). CP: cerebral peduncle. The dotted outline shows the extent of the STN in the sham-lesioned rat. Note the cell loss in the STN in the lesioned rat. Right-hand diagrams: representation of the approximate area of destruction of the STN in the lesioned group. Drawings were made from the microscopic sections, and were superimposed on the relevant pages from Paxinos and Watson’s [38] stereotaxic atlas. The black area in the region of the STN represents the smallest, and the surrounding grey area the largest extent of the lesion. LV: lateral ventricle; 3V: third ventricle.